Tiziana Life Sciences Stock Discussion

$Tiziana Life Sciences(TLSA.US)$ Reuters· 1 min ago
FDA Accepts Tiziana Life Sciences Fast Track Designation Submission for Treatment of Multiple Sclerosis

$Tiziana Life Sciences(TLSA.US)$ Tiziana Life Sciences Announces Six-Month Qualitative Improvement in Neuroimaging in 80% of Multiple Sclerosis Patients Receiving Intranasal Foralumab

My Money Says This $1 Penny Stock Could Reclaim Its Previous $12 High
Check out the video above.
$Tiziana Life Sciences(TLSA.US)$

$Tiziana Life Sciences(TLSA.US)$
Tiziana Life Sciences Submits Grant Application to ALS Association to Fund Clinical Trial of Intranasal Foralumab
Tiziana Life Sciences (Nasdaq: TLSA), a biotechnology company, has applied for a grant from the ALS Association to fund a clinical trial for intranasal foralumab, an anti-CD3 monoclonal antibody. The grant is part of the Hoffman ALS Clinical Trial Awards Program. The trial aims to evaluate the safety, dosing, and biomarkers of foralumab in ALS pat...

$Tiziana Life Sciences(TLSA.US)$ I wish TLSA would do a rocket move to the moon over night.

$Tiziana Life Sciences(TLSA.US)$ Tiziana Life Sciences: Files for Orphan Drug Designation for Intranasal Foralumab to Treat Non-Active Secondary Progressive Multiple Sclerosis

$Tiziana Life Sciences(TLSA.US)$
NEWS
Tiziana Life Sciences Files for Orphan Drug Designation for Intranasal Foralumab
Tiziana Life Sciences, a biotechnology company, files for Orphan Drug Designation for intranasal foralumab for treating non-active secondary progressive Multiple Sclerosis, aiming to be the first therapy to receive this designation. Supported by clinical evidence, the drug has shown positive results in an Expanded Access Program, improving fatigue in 70% of patients. A Phase 2a ...

$Tiziana Life Sciences(TLSA.US)$ I just know one day TLSA will go up and away.

$Tiziana Life Sciences(TLSA.US)$ Tiziana Life Sciences Announces FDA Allowance for Additional Twenty Patients to Be Enrolled in the Intranasal Foralumab Multiple Sclerosis Expanded Access Program

$Tiziana Life Sciences(TLSA.US)$ Tiziana Life Sciences Says Study Results From Intranasal Anti-CD3 Foralumab In Multiple Sclerosis Patients With PIRA Highlighted In Neurology Today!                                                Says that treatment shows potential